Greenstone Biosciences, Inc. — Form D
Greenstone Biosciences, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-04. The offering totals $11.2M, of which $10.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-05-04
- Form: D
- Accession: 0001923859-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.2M
- Amount sold: $10.2M
- Remaining: $1.0M
- Minimum investment: $20K
- Investors: 20
- Date of first sale: 2022-04-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-444422
Issuer
- Name: Greenstone Biosciences, Inc.
- CIK: 0001923859
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3160 PORTER DRIVE, PALO ALTO, CA, 94304
- Phone: 6507147060
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Jade Chao | Executive Officer | Palo Alto, CA |
More